CardioGenics Holdings Inc (CGNH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2015 | 22.73 Thousand USD | 1815.67% |
| 2014 | 1187.00 USD | -57.65% |
| 2013 | 2803.00 USD | 111.5% |
| 2012 | -24.38 Thousand USD | 96.2% |
| 2011 | -640.86 Thousand USD | 64.45% |
| 2010 | -1.8 Million USD | 24.52% |
| 2009 | -2.38 Million USD | -768.02% |
| 2008 | -275.16 Thousand USD | -110.56% |
| 2007 | 2.6 Million USD | 65.35% |
| 2006 | 1.57 Million USD | 24.5% |
| 2005 | 1.26 Million USD | 427.81% |
| 2004 | -386.28 Thousand USD | -1563.79% |
| 2003 | -23.21 Thousand USD | -105.91% |
| 2002 | 392.89 Thousand USD | 3023.75% |
| 2001 | -13.43 Thousand USD | -101.57% |
| 2000 | 856.72 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2016 Q1 | 281.68 Thousand USD | 1138.78% |
| 2015 Q1 | 5200.00 USD | 338.08% |
| 2015 Q4 | 22.73 Thousand USD | -73.12% |
| 2015 FY | 22.73 Thousand USD | 1815.67% |
| 2015 Q3 | 84.6 Thousand USD | 25.95% |
| 2015 Q2 | 67.17 Thousand USD | 1191.77% |
| 2014 Q4 | 1187.00 USD | -99.76% |
| 2014 FY | 1187.00 USD | -57.65% |
| 2014 Q1 | 201.08 Thousand USD | 7073.81% |
| 2014 Q2 | 379.21 Thousand USD | 88.59% |
| 2014 Q3 | 504.73 Thousand USD | 33.1% |
| 2013 FY | 2803.00 USD | 111.5% |
| 2013 Q2 | -9902.00 USD | 94.45% |
| 2013 Q4 | 2803.00 USD | 102.47% |
| 2013 Q3 | -113.45 Thousand USD | -1045.75% |
| 2013 Q1 | -178.5 Thousand USD | -632.13% |
| 2012 Q4 | -24.38 Thousand USD | 62.63% |
| 2012 Q3 | -65.24 Thousand USD | 74.65% |
| 2012 FY | -24.38 Thousand USD | 96.2% |
| 2012 Q1 | -349.08 Thousand USD | 45.53% |
| 2012 Q2 | -257.35 Thousand USD | 26.28% |
| 2011 FY | -640.86 Thousand USD | 64.45% |
| 2011 Q4 | -640.86 Thousand USD | 40.71% |
| 2011 Q3 | -1.08 Million USD | 29.83% |
| 2011 Q2 | -1.54 Million USD | 16.09% |
| 2011 Q1 | -1.83 Million USD | -1.83% |
| 2010 FY | -1.8 Million USD | 24.52% |
| 2010 Q3 | -767.45 Thousand USD | 43.25% |
| 2010 Q4 | -1.8 Million USD | -134.92% |
| 2010 Q1 | -1.87 Million USD | 21.64% |
| 2010 Q2 | -1.35 Million USD | 27.74% |
| 2009 Q1 | -39.12 Thousand USD | 90.01% |
| 2009 FY | -2.38 Million USD | -768.02% |
| 2009 Q4 | -2.38 Million USD | 20.58% |
| 2009 Q3 | -3 Million USD | -2730.6% |
| 2009 Q2 | -106.25 Thousand USD | -171.54% |
| 2008 Q2 | -59.01 Thousand USD | -19.24% |
| 2008 FY | -275.16 Thousand USD | -110.56% |
| 2008 Q4 | -391.78 Thousand USD | -42.38% |
| 2008 Q3 | -275.16 Thousand USD | -366.26% |
| 2008 Q1 | -49.49 Thousand USD | -104.98% |
| 2007 Q1 | 2.33 Million USD | 8.07% |
| 2007 Q2 | 2.47 Million USD | 6.05% |
| 2007 Q4 | 994.41 Thousand USD | -61.85% |
| 2007 Q3 | 2.6 Million USD | 5.26% |
| 2007 FY | 2.6 Million USD | 65.35% |
| 2006 FY | 1.57 Million USD | 24.5% |
| 2006 Q4 | 2.16 Million USD | 37.06% |
| 2006 Q1 | 1.88 Million USD | 17.28% |
| 2006 Q2 | 1.96 Million USD | 4.36% |
| 2006 Q3 | 1.57 Million USD | -19.91% |
| 2005 Q4 | 1.6 Million USD | 27.0% |
| 2005 FY | 1.26 Million USD | 427.81% |
| 2005 Q2 | 918.49 Thousand USD | 1705.16% |
| 2005 Q3 | 1.26 Million USD | 37.87% |
| 2005 Q1 | -57.22 Thousand USD | 74.21% |
| 2004 FY | -386.28 Thousand USD | -1563.79% |
| 2004 Q4 | -221.86 Thousand USD | 42.56% |
| 2004 Q3 | -386.28 Thousand USD | 56.82% |
| 2004 Q2 | -894.64 Thousand USD | -432.65% |
| 2004 Q1 | 268.94 Thousand USD | 12.68% |
| 2003 Q3 | -23.21 Thousand USD | -149.79% |
| 2003 Q4 | 238.68 Thousand USD | 1128.06% |
| 2003 Q2 | 46.63 Thousand USD | 109.13% |
| 2003 FY | -23.21 Thousand USD | -105.91% |
| 2003 Q1 | -510.93 Thousand USD | -374.91% |
| 2002 Q4 | -107.58 Thousand USD | -127.38% |
| 2002 Q1 | -53.5 Thousand USD | -134.09% |
| 2002 Q2 | 363.67 Thousand USD | 779.73% |
| 2002 Q3 | 392.89 Thousand USD | 8.04% |
| 2002 FY | 392.89 Thousand USD | 3023.75% |
| 2001 Q2 | -144.31 Thousand USD | -109.33% |
| 2001 FY | -13.43 Thousand USD | -101.57% |
| 2001 Q1 | 1.54 Million USD | 5.29% |
| 2001 Q4 | -22.85 Thousand USD | -70.08% |
| 2001 Q3 | -13.43 Thousand USD | 90.69% |
| 2000 Q3 | 856.72 Thousand USD | 165.3% |
| 2000 Q2 | -1.31 Million USD | 64.2% |
| 2000 Q1 | -3.66 Million USD | 0.0% |
| 2000 FY | 856.72 Thousand USD | 0.0% |
| 2000 Q4 | 1.46 Million USD | 71.44% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 98.969% |
| Arrayit Corporation | 1.05 Million USD | 97.846% |
| Atlantic International Corp. | 236.49 Thousand USD | 90.385% |
| Biocept, Inc. | -788 Thousand USD | 102.886% |
| Bioqual, Inc. | -12 Million USD | 100.189% |
| DermTech, Inc. | 17.65 Million USD | 99.871% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.004% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 100.308% |
| iMD Companies, Inc. | 1.11 Million USD | 97.962% |
| IDenta Corp. | 524.85 Thousand USD | 95.668% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 99.704% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 184.369% |
| InVitro International | -313.14 Thousand USD | 107.262% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 98.548% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 3289.201% |
| Medical Imaging Corp. | 3.79 Million USD | 99.4% |
| NovelStem International Corp. | 3.52 Million USD | 99.354% |
| Optigenex Inc. | 8.93 Million USD | 99.745% |
| PharmChem, Inc. | -1.49 Million USD | 101.522% |
| Proteome Sciences plc | 14.57 Million USD | 99.844% |
| Response Genetics, Inc | -13.08 Million USD | 100.174% |
| Rennova Health, Inc. | 14.82 Million USD | 99.847% |
| RushNet, Inc. | 4.8 Million USD | 99.526% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 83.229% |
| Stella Diagnostics Inc. | 6.19 Million USD | 99.633% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 98.726% |
| Todos Medical Ltd. | 38.31 Million USD | 99.941% |